All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Liver Diseases-26202119

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	26202119	G119R	S	S	Liver Diseases	G R I L	View
2	26202119	G145R	S	S	Liver Diseases	G R I L	View
3	26202119	M133L	S	S	Liver Diseases	G R I L	View
4	26202119	M133T	S	S	Liver Diseases	G R I L	View
5	26202119	P120Q	S	S	Liver Diseases	G R I L	View
6	26202119	P120T	S	S	Liver Diseases	G R I L	View
7	26202119	P127T	S	S	Liver Diseases	G R I L	View
8	26202119	Q129H	S	S	Liver Diseases	G R I L	View
9	26202119	Q129R	S	S	Liver Diseases	G R I L	View
10	26202119	T123A	S	S	Liver Diseases	G R I L	View
11	26202119	T140I	S	S	Liver Diseases	G R I L	View
12	26202119	C124Y	S	S	Liver Diseases	R L	View
13	26202119	C139Y	S	S	Liver Diseases	R L	View
14	26202119	C147F	S	S	Liver Diseases	R L	View
15	26202119	G144A	S	S	Liver Diseases	R L	View
16	26202119	G130R	S	S	Liver Diseases	R L	View
17	26202119	K122N	S	S	Liver Diseases	R I L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.